References
- Gao H, Obach RS. (2011). Addressing MIST (Metabolites in Safety Testing): bioanalytical approaches to address metabolite exposures in humans and animals. Curr Drug Metab 12:578–586.
- Lappin G, Seymour M. (2010). Addressing metabolite safety during first-in-man studies using ¹4C-labeled drug and accelerator mass spectrometry. Bioanalysis 2:1315–1324.
- Obach RS, Nedderman AN, Smith DA. (2012). Radiolabelled mass-balance excretion and metabolism studies in laboratory animals: are they still necessary? Xenobiotica 42:46–56.
- Roffey SJ, Obach RS, Gedge JI, Smith DA. (2007). What is the objective of the mass balance study? A retrospective analysis of data in animal and human excretion studies employing radiolabeled drugs. Drug Metab Rev 39:17–43.
- White RE, Evans DC, Hop CECA, Moore DJ, Prakash C, Surapaneni S, Tse FLS. (2013). Radiolabelled mass-balance excretion and metabolism studies in laboratory animals: a commentary on why they are still necessary. Xenobiotica 43:219–225.